PD-0270: A survey of radiotherapy skin care practice across Europe and the United States of America  by Coleman, M. & O'Donovan, A.
2nd ESTRO Forum 2013  S105 
	
registration was carried out on a predefined day of the week. 
Proportions were compared using Fisher's Exact test.  
Results: For patients evaluated on a fixed treatment fraction (October 
2011), 58 CTC registrations out of 134 (0.43, 95% CI: 0.39–0.48) 
planned registrations were recorded. For patients evaluated on a 
predefined weekday (October 2012), 83 CTC registrations were 
performed out of 108 possible (0.77, 0.72–0.81). The absolute 
difference in the proportions of registrations performed was 0.34 (95% 
CI: 0.21–0.45, p<0.0001). Of the 20 patients treated in October 2011, 
19 (0.95, 95% CI: 0.84–0.99) received medical treatment of their acute 
side effects administered by a RTN, by the use of prior delegated 
medical interventions (i.e. no physician involvement). In October 
2012, only 12 of the 20 patients (0.60, 0.46–0.72) received medical 
treatment. This corresponds to an absolute decrease in medical 
treatment of acute side-effects by 0.35 (0.10–0.58, p=0.02). 
Conclusions: We found an increased number of planned registrations 
performed as well as a decrease in the number of patients in need of 
medical treatment of acute side effects. This is believed to reflect 
that improved CTC registration results in more effective early nursing 
interventions from the RTN. The pre-defined levels in the CTC-system 
and the prior delegated medical intervention options allow for quick 
and independent response to acute RT toxicity by the RTN. As an 
added benefit, systematic CTC registrations will provide additional 
and improved scientific data on patients' tolerance to RT. 
As this is a retrospective study comparing two patient cohorts, there 
may be an effect of simply introducing a new procedure on the 
compliance with planned toxicity scoring. However, the decrease in 
medical interventions following an increased focus on consistent 
toxicity scoring is nevertheless of interest. 
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Purpose/Objective: Severe acute radiation-induced skin reactions 
occur in a significant proportion of women who receive radiation 
therapy for breast cancer. We previously showed that Mepilex Lite 
dressings decreased the severity of erythema. Here we report their 
effect on the full range of skin reactions in 74 breast cancer patients 
post-mastectomy.  
Materials and Methods: A total of 80 women were recruited from four 
hospitals in New Zealand with 74 women contributing a full data set 
for analysis. The first skin area on the chest wall to develop erythema 
was randomly divided into two similar halves; one half was treated 
with Mepilex Lite dressings, the other half with aqueous cream. Skin 
reactions were assessed using the Radiation-Induced Skin Reaction 
Assessment Scale (RISRAS).  
Results: Compared with aqueous cream, Mepilex Lite dressings did not 
significantly reduce the incidence of moist desquamation but did 
reduce the overall severity of skin reactions by 41%, the average moist 
desquamation score by 49% and the sum of the moist desquamation 
time for all patches by 28% (see table below). Most patients preferred 
the dressings, found them easy to use and very comfortable to wear. 
 
Table1: Key trial results 
Measures Aqueous Cream Mepilex 
p values 
RISRAS (combined) 3.02 ± 0.29 1.77 ± 0.12 <0.001 (t-test) 
RISRAS (moist 
desquamation) 0.37 0.18 
0.043 (t-test) 
Incidence of moist 
desquamation 19% 15%  
0.55 
(binomial) 
Time to moist 
desquamation 49.9 ± 3.3 days 40.3 ± 2.7 days 
0.93 (PROC
MIXED)  
Time to healing 12.5 ± 1.5 days 11.4 ± 1.7 days 
0.66 (PROC
MIXED) 
Total moist 
desquamation time 25 weeks 18 weeks 
NA 
 
Conclusions: Mepilex Lite dressings reduce all aspects of radiation-
induced skin reactions. 
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Purpose/Objective: Radiation induced toxicity is a common adverse 
side effect of radiation therapy. Radiotherapy may cause varying 
degrees of physical skin reactions, and contribute to a patient’s 
overall quality of life. A recent Society and College of Radiographers 
(SCoR) survey of skincare practice in the UK highlighted a lack of 
convincing evidence to support skincare advice for radiotherapy 
patients in relation to prevention and management of skin reactions.  
The purpose of this research study was to investigate current skin care 
practice for radiotherapy patients across Europe and the United States 
of America (USA). The published literature was used as a guide to 
assess the appropriateness of current clinical guidelines. 
Materials and Methods: A link to an online survey, using 
'SurveyMonkey' was emailed to departments (N=737) across Europe and 
the USA. This survey was based on a questionnaire from the SCoR 
study, which was adapted, with permission, for a wider radiotherapy 
community. Each radiotherapy department manager was asked to 
select one radiation therapist per department to complete the survey. 
Data was collected and analysed using SPSS version 20.0 and Microsoft 
excel. 
Results: One hundred and eighty one departments responded, giving a 
response rate of 25%. Results of the survey highlight disparities 
between clinical practice and research findings. Information provided 
to patients on how to manage their skin during radiotherapy is often 
inconsistent and outdated. A plethora of agents is used in a non-
standardised manner.  
Based on the results of this study, and current literature, an evidence-
based skincare information leaflet for patients was devised.  
Conclusions: A large variation was seen between departments with 
regard to current skincare practice. It highlights the need for further 
studies to be carried out in order to develop an evidence base for the 
skincare advice given to radiotherapy patients, and to eliminate non-
standardised practice.  
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Purpose/Objective: It is of importance to take the shoulder position 
into account when planning radiotherapy for head and neck cancer 
patients. The purpose of this study is: 1) to evaluate how 
interfractional variations of the shoulder position affect the dose 
distribution for RA compared to IMRT and 2) to develop an 
optimisation method for RA treatment planning in order to increase 
robustness to shoulder position variations.  
Materials and Methods: One IMRT and two RA treatment plans (TPs) 
were made for a number of patients. The two RA TPs (RA anisotropic 
and RA isotropic) were prepared with and without taking the shoulders 
into account in the optimisation, respectively. The former was done 
with different methods e.g. using optimisation objectives on the 
delineated shoulders, by using avoiding sectors, or a combination of 
the two methods. The robustness of the different techniques and the 
different methods was investigated by simulating different shoulder 
positions in the treatment planning system. The body outline was 
edited to simulate when shoulders 'falls down' and 'moves up' and the 
original TPs were applied on the corresponding structure sets. 
Changes in dose distribution and dosimetric parameters e.g. CTV 
volume covered by 95% of the prescribed dose (V95(CTV)), dose max 
to ORs etc. was used to investigate the robustness of the TPs for the 
simulated shoulder positions. For relevant cases the body outlines 
from CBCT-scans acquired during the course of treatment, were 
transferred to the original CT set, in order to investigate how the 
shoulder position affect the dose in clinical situations.  
Results: The figure illustrates simulated cases where the shoulders 
'move up' 1 cm and 1.5 cm and how this affects the dose distribution 
for the IMRT, RA isotropic and RA anisotropic TPs, respectively. The 
IMRT plan was created with fixed beam angle geometry that takes the 
shoulders into account. As expected the IMRT was robust for 
interfractional variation of the shoulder position e.g. V95(CTV)=100%, 
for all simulated IMRT cases. The RA TPs were robust (e.g. 
V95(CTV)=100%) for small movements (1cm or less). If the shoulder 
 
 
